ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 914,99
-0,88%
Dow Jones
37 903,29
0,23%
DAX
17 914,99
-0,04%
Brent Oil
84,065
0,63%
Bitcoin
57 686,44
-0,95%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Taro Pharmaceutical Industries Ltd (TARO)

  7. Taro Pharmaceutical Industries Ltd (TARO) Actualités

TARO Taro Pharmaceutical Industries Ltd

42,39
0,00 (0,00%)
Avant marché
Dernière mise à jour : 10:00:00
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Taro Pharmaceutical Industries Ltd TARO NYSE Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 42,39 10:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
42,39
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
15/4/202414:00BWTaro Announces Extraordinary General Meeting and Ordinary..
11/3/202411:19EDGAR2Form SC 13E3/A - Going private transaction by certain..
15/2/202414:36EDGAR2Form SC 13E3 - Going private transaction by certain issuers
30/1/202419:18PRNUSKuehn Law Encourages PGTI, TAST, TARO, and ANSS Investors to..
30/1/202413:00PRNUSKrensavage Asset Management Remains Opposed to Sun's..
26/1/202415:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/1/202423:06BWTaro Provides Results for December 31, 2023
19/1/202422:15BWTaro to Release Third Quarter Results on January 25, 2024
17/1/202422:36EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/1/202422:35EDGAR2Form SC 13D/A - General statement of acquisition of..
17/1/202422:30PRNCATaro Announces Merger Agreement with Sun Pharma
04/1/202422:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/12/202322:31EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/12/202322:30EDGAR2Form SC 13D/A - General statement of acquisition of..
17/11/202322:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/10/202315:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/10/202323:00BWTaro Provides Results for September 30, 2023
19/10/202322:30BWTaro to Release Second Quarter Results on October 26, 2023
27/7/202316:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/7/202302:36BWTaro Provides Results for the Quarter Ended June 30, 2023
19/7/202322:00BWTaro to Release First Quarter Results on July 26, 2023
19/7/202313:00PRNUSKrensavage Asset Management Opposes Sun's Lowball Bid for..
30/6/202315:00BWTaro Annual Report on Form 20-F Available For Fiscal Year..
29/6/202322:32EDGAR2Form 20-F - Annual and transition report of foreign private..
28/6/202323:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/5/202301:00BWTaro Provides Results for Year Ended March 31, 2023
18/5/202322:46BWTaro to Release Full Year Results on May 23, 2023

Dernières Valeurs Consultées

NYSE
TARO
Taro Pharmaceutical Indu...
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés